Solara Active Pharma Sciences Ltd

SOLARAPP1

Company Profile

  • Business description

    Solara Active Pharma Sciences Ltd is engaged in the Active Pharmaceutical Ingredients (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinoid, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant, and others. It also offers contract services, including contract development and manufacturing, and analytical services. Geographically, the company generates all of its revenue from India.

  • Contact

    Phase II - CSIR Road
    Module No. 601, 602, 603, Ticel Bio Park
    Taramani
    ChennaiTN600113
    IND

    T: +91 4447406200

    https://www.solara.co.in

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    2,924

Stocks News & Analysis

stocks

Overvalued ASX share as market underestimates downside risks

Growth outlook solid, but upside more than priced in.
stocks

New production imminent for undervalued ASX gas play

LNG project receives first commissioning gas.
stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,290.606.800.07%
CAC 408,174.2014.39-0.18%
DAX 4023,830.99441.20-1.82%
Dow JONES (US)46,190.61238.370.52%
FTSE 1009,354.5781.52-0.86%
HKSE25,766.24519.142.06%
NASDAQ22,679.97117.440.52%
Nikkei 22548,846.691,264.542.66%
NZX 50 Index13,301.0911.880.09%
S&P 5006,664.0134.940.53%
S&P/ASX 2008,994.306.100.07%
SSE Composite Index3,862.6022.840.59%

Market Movers